在欧洲资助跨国研究人员发起的临床研究:为什么以及如何?
Marta Del Álamo1, Sabrina Lémeret2, Cristina Nieto3
1European Clinical Research Infrastructure Network (ECRIN), Paris, France. marta.delalamo@ecrin.org.
Trials
|October 18, 2024
概括
研究人员发起的临床研究 (IICS) 解决了行业忽视的重要健康问题. 支持跨国IICS需要不断发展的融资策略,以克服障碍并促进关键的非商业研究.
科学领域:
- 临床研究 临床研究
- 医疗保健服务研究 医疗服务研究
- 翻译医学是一种翻译医学.
背景情况:
- 研究人员发起的临床研究 (IICS) 解决了关键的研究差距,而这些差距往往被行业资助的研究所忽视.
- 这些研究重点关注药物重用,治疗优化和创新疗法,具有重要的社会价值.
- 多国IICS通过多样化的患者参与和科学合作来提高数据质量和概括性.
研究的目的:
- 强调支持跨国研究人员发起的临床研究 (IICSs) 的重要性.
- 讨论跨国IICS的目标和当前的欧洲融资机制.
- 提出发展融资的策略,以减轻已识别的障碍.
主要方法:
- 该研究回顾了与跨国IICSs相关的理由和挑战.
- 它检查了欧洲现有的融资格局和障碍.
- 它讨论了适应性融资策略的必要性.
主要成果:
- 资金是IICS,特别是跨国临床试验 (IICT) 的首要挑战.
- 障碍包括预算限制,跨国资金转移的不灵活性,招标规则和复杂的成本报告.
- 欧洲目前的融资机制需要不断发展才能有效支持这些研究.
结论:
- 跨国IICS对于解决行业未优先考虑的高影响力的医疗保健问题至关重要.
- 资助策略必须适应克服已识别的障碍,确保继续重要的学术研究.
- 加强对跨国IICS的支持,将有助于产生可通用的证据和创新的医疗保健解决方案.
相关概念视频
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...